Milestone Pharmaceuticals Inc (NAS:MIST)
$ 1.71 -0.04 (-2.29%) Market Cap: 91.08 Mil Enterprise Value: 54.10 Mil PE Ratio: 0 PB Ratio: 2.28 GF Score: 29/100

Milestone Pharmaceuticals Inc at Jefferies Healthcare Conference Transcript

Jun 09, 2023 / 12:30PM GMT
Release Date Price: $3.95 (-1.25%)
Chris Howerton
Jefferies - Analyst

Okay. Good morning, everybody. Thank you so much for joining us. My name is Chris Howerton, part of the Jefferies biotechnology research team; very excited to see everybody here for the final day of our conference and then, of course, to be hosting a fireside chat with one of the companies I cover, Milestone Pharmaceuticals. So thanks for joining us, gentlemen. I hope you're having a good morning.

Joe Oliveto
Milestone Pharmaceuticals Inc. - President & CEO

Yeah, same to you, Chris. Thanks so much to the colleagues at Jefferies were for inviting us.

Questions & Answers

Chris Howerton;Joe Oliveto
Jefferies - Analyst;Milestone

Awesome. Well, great, so I guess I should have introduced everybody Joe Oliveto, the CEO, David Bharucha, the CMO; and Lorenz Muller, the CCO if I have it right. And so I guess, Joe, maybe you could start us off. Do you have an elevator pitch or an overview for the company? You could just level set for us.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot